Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Study of TVB-2640 in Subjects With Non-Alcoholic Steatohepatitis (NASH)

Phase: N/A Priority: Normal
NCT ID: NCT03938246 Org: User:
Start: 03/22/19 End: 10/02/21 Due: 10/02/22

A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT05835180 Org: User:
Start: 05/01/23 End: 12/18/23 Due: 12/18/24

Open-label Study of the Absorption, Metabolism, and Excretion of [14C]TVB-2640 Following a Single Oral Dose in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05657834 Org: User:
Start: 11/21/22 End: 12/21/22 Due: 12/21/23

A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH

Phase: N/A Priority: Normal
NCT ID: NCT06692283 Org: User:
Start: 03/31/25 End: 06/30/27 Due: 06/30/28

A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT06594523 Org: User:
Start: 03/31/25 End: 12/31/30 Due: 12/31/31

A Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02223247 Org: User:
Start: 11/30/13 End: 06/30/17 Due: 06/30/18

Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne

Phase: N/A Priority: Normal
NCT ID: NCT06989840 Org: User:
Start: 05/19/25 End: 01/01/26 Due: 01/01/27

Study of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)

Phase: N/A Priority: Normal
NCT ID: NCT04906421 Org: User:
Start: 08/12/21 End: 10/02/23 Due: 10/02/24